These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34338567)

  • 1. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
    Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
    Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs of scutellarin: ethyl, benzyl and N,N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats.
    Cao F; Guo JX; Ping QN; Liao ZG
    Eur J Pharm Sci; 2006 Dec; 29(5):385-93. PubMed ID: 16997537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
    Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
    Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.
    Hu L; Quach T; Han S; Lim SF; Yadav P; Senyschyn D; Trevaskis NL; Simpson JS; Porter CJ
    Angew Chem Int Ed Engl; 2016 Oct; 55(44):13700-13705. PubMed ID: 27482655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats.
    Liu XB; Ye JX; Quan LH; Liu CY; Deng XL; Yang M; Liao YH
    Eur J Pharm Biopharm; 2008 Nov; 70(3):845-52. PubMed ID: 18675905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
    Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
    Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ester prodrug of scutellarin: synthesis, physicochemical property and degradation].
    Cao F; Guo JX; Ping QN; Shao Y; Liang J
    Yao Xue Xue Bao; 2006 Jul; 41(7):595-602. PubMed ID: 17007349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Intestinal Digestion and On Site Tumor-Bioactivation are the Two Important Determinants for Chylomicron-Mediated Lymph-Targeting Triglyceride-Mimetic Docetaxel Oral Prodrugs.
    Tian C; Guo J; Wang G; Sun B; Na K; Zhang X; Xu Z; Cheng M; He Z; Sun J
    Adv Sci (Weinh); 2019 Dec; 6(24):1901810. PubMed ID: 31871861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.
    Yang X; Miao X; Cao F; Li S; Ai N; Chang Q; Lee SMY; Zheng Y
    J Pharm Sci; 2014 Nov; 103(11):3576-3584. PubMed ID: 25187229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
    Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
    J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intestinal lymphatic transport of breviscapine orally administered in rat].
    Gong YJ; Wang JX; Zhang Y; Shen M; Fu CM; Shen T
    Yao Xue Xue Bao; 2011 Oct; 46(10):1262-7. PubMed ID: 22242462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mrp2-related efflux of scutellarin in the intestinal absorption in rats.
    Cao F; Zhang H; Guo J; Ping Q
    Pharmazie; 2008 Jan; 63(1):75-80. PubMed ID: 18271309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The synthesis, characterization and in situ intestinal absorption of different molecular weight scutellarin-PEG conjugates].
    Zhou Q; Jiang X; Li K; Fan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):353-6, 387. PubMed ID: 16706365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
    Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
    Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
    Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
    Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of lipophilic ester prodrugs of dolutegravir for intestinal lymphatic transport.
    Chu Y; Wong A; Chen H; Ji L; Qin C; Feng W; Stocks MJ; Gershkovich P
    Eur J Pharm Biopharm; 2023 Oct; 191():90-102. PubMed ID: 37634824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.